E ndovascular therapy (ET) is an increasingly used therapeutic strategy in acute ischemic stroke.1 The administration of contrast material during ET often results in high attenuation areas on postprocedural brain computed tomography (CT) related to blood-brain barrier (BBB) breakdown, although their clinical significance is conflicting.2-8 Early differentiation between contrast enhancement and brain hemorrhage may be of assistance to detect bleeding complications and anticipate the start of antithrombotic therapy after thrombolysis. 9 However, in the early post-ET period, this distinction is not feasible using conventional post-treatment CT. [2][3][4][5]10 Dual-energy CT (DE-CT) is a relatively new technique that allows for a reliable differentiation between tissue high attenuation areas related to iodine contrast material extravasation and parenchymal hemorrhage.11-13 The technique is based on the different attenuation effects of normal brain tissue, iodine, and blood at different irradiation energy levels. In patients receiving ET, DE-CT has shown a good accuracy for early differentiation between hemorrhage and contrast extravasation, but these studies did not address specifically the prognostic implications of this segregation. 12,14,15 Brain ischemia induces time-dependent changes in microvascular integrity and these changes may lead to the extravasation of contrast molecules and cellular blood elements from microvessels leading to hemorrhagic complications. 16,17 Thus, the ability of DE-CT to differentiate between contrast and brain hemorrhage after ET may allow discriminating between different grades BBB disruption. The aim of the study was to evaluate the prognostic significance of the presence of contrast Background and Purpose-Computed tomographic (CT) high attenuation (HA) areas after endovascular therapy for acute ischemic stroke are a common finding indicative of blood-brain barrier disruption. Dual-energy CT allows an accurate differentiation between HA areas related to contrast staining (CS) or to brain hemorrhage (BH). We sought to evaluate the prognostic significance of the presence of CS and BH after endovascular therapy. Methods-A prospective cohort of 132 patients treated with endovascular therapy was analyzed. According to dual-energy CT findings, patients were classified into 3 groups: no HA areas (n=53), CS (n=32), and BH (n=47). The rate of new hemorrhagic transformations was recorded at follow-up neuroimaging. Clinical outcome was evaluated at 90 days with the modified Rankin Scale (poor outcome, 3-6). Results-Poor outcome was associated with the presence of CS (odds ratio [OR], 11.3; 95% confidence interval, and BH (OR, 10.4; 95% confidence interval,